JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M103720200 on June 26, 2001

J. Biol. Chem., Vol. 276, Issue 34, 31535-31541, August 24, 2001
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/34/31535    most recent
M103720200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Segall, L.
Right arrow Articles by Blostein, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Segall, L.
Right arrow Articles by Blostein, R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Mechanistic Basis for Kinetic Differences between the Rat alpha 1, alpha 2, and alpha 3 Isoforms of the Na,K-ATPase*

Laura Segall, Stewart E. Daly, and Rhoda BlosteinDagger

From the Department of Biochemistry and Medicine, McGill University, Montreal, Quebec H3G 1A4, Canada

Received for publication, April 25, 2001, and in revised form, June 14, 2001

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Previous studies showed that the alpha 1, alpha 2, and alpha 3 isoforms of the catalytic subunit of the Na,K-ATPase differ in their apparent affinities for the ligands ATP, Na+, and K+. For the rat isoforms transfected into HeLa cells, K'ATP for ATP binding at its low affinity site is lower for alpha 2 and alpha 3 compared with alpha 1; relative to alpha 1 and alpha 2, alpha 3 has a higher K'Na and lower K'K (Jewell, E. A., and Lingrel, J. B (1991) J. Biol. Chem. 266, 16925-16930; Munzer, J. S., Daly, S. E., Jewell-Motz, E. A., Lingrel, J. B, and Blostein, R. (1994) J. Biol. Chem. 269, 16668-16676). The experiments described in the present study provide insight into the mechanistic basis for these differences. The results show that alpha 2 differs from alpha 1 primarily by a shift in the E1 right-left-harpoons  E2 equilibrium in favor of E1 form(s) as evidenced by (i) a ~20-fold increase in IC50 for vanadate, (ii) decreased catalytic turnover, and (iii) notable stability of Na,K-ATPase activity at acidic pH. In contrast, despite its lower K'ATP compared with alpha 1, the E1 right-left-harpoons  E2 poise of alpha 3 is not shifted toward E1. Distinct intrinsic interactions with Na+ ions are underscored by the marked selectivity for Na+ over Li+ of alpha 3 compared with either alpha 1 or alpha 2 and higher K'Na for cytoplasmic Na+, which persists over a 100-fold range in proton concentration, independent of the presence of K+. The kinetic analysis also suggests alpha 3-specific differences in relative rates of partial reactions, which impact this isoform's distinct apparent affinities for both Na+ and K+.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The Na,K-ATPase or sodium pump is an integral membrane protein complex that couples the exchange of three intracellular Na+ ions for two extracellular K+ ions to the hydrolysis of one molecule of ATP. The sodium pump is essential to the maintenance of the electrochemical gradients of Na+ and K+ across the plasma membrane of virtually all animal cells and consequently provides the driving force for the transport of nutrients such as glucose and amino acids into the cell. This enzyme is a P-type ATPase transporter and, as such, is directly phosphorylated on a conserved aspartate residue within its cytoplasmic domain. Both the phosphorylated and dephosphorylated forms of the enzyme exist in at least two states that undergo conformational transitions (E1P right-arrow E2P and E2 right-arrow E1) that are coupled to the ion-translocating steps.

The Na,K-ATPase comprises two essential subunits: a large catalytic alpha  subunit (~110 kDa), containing the phosphorylation site as well as the binding sites for Na+, K+, ATP and for the cardiac glycoside ouabain, and a smaller, highly glycosylated beta  subunit (~35-55 kDa) that ensures the proper folding and delivery of the alpha  subunit to the plasma membrane, possibly also modulating cation affinity (1, 2). A third subunit, gamma  (~7 kDa), was found in the kidney (3), where it functions as a regulator of the pump (for a review, see Ref. 4). Several isoforms of alpha  and beta  have been described. In the case of alpha , there are four known isoforms that are expressed in a tissue- and development-specific manner. In the rat, they are distributed as follows. alpha 1 is the ubiquitous, "housekeeping" isoform; alpha 2 is expressed in muscle, nerves, and adult heart; alpha 3 is present in nerves, brain, and fetal heart; and recently the protein for alpha 4 was found in rat testis, where it may participate in spermatogenesis and sperm motility (5, 6). For a comprehensive review on Na,K-ATPase isozyme structure and diversity in function, see Ref. 7.

Both our laboratory and others have compared the functional properties of the alpha 1, alpha 2*, and alpha 3* isoforms of the rat Na,K-ATPase within the same mammalian membrane environment following transfection of their cDNAs into HeLa cells. (alpha 2* and alpha 3* are the rat alpha 2 and alpha 3 isoforms rendered relatively resistant to ouabain, to permit their distinction from endogenous ouabain sensitive enzyme (8).) The results showed that the isozymes exhibit differences in their apparent ligand affinities (see Table I). Both alpha 2* and alpha 3* have a 3-fold higher apparent affinity for ATP binding (low affinity site) compared with the alpha 1 isoform (K'ATP values of 120 and 130 µM, respectively, compared with 331 µM) (9). In addition, while alpha 1 and alpha 2* show similar apparent affinities for Na+ and K+, measurements both in broken membranes and in intact cells revealed a lower apparent affinity of alpha 3* for intracellular Na+ and a higher apparent affinity for extracellular K+ (9, 10).

The present study investigates whether the aforementioned differences in apparent affinities for ligands are the consequence of primary differences in ligand interactions or whether and to what extent they reflect differences in the E1 right-left-harpoons  E2 conformational equilibrium. The results of the present study, together with our earlier work (11), show that the kinetic differences of the alpha 2* isoform are a consequence of a shift in the poise of the conformational equilibrium toward the E1 form of the enzyme. In the case of alpha 3*, the mechanistic basis for the observed differences in ligand binding is less straightforward. The notable differences in apparent cation affinities are not explained by a shift in the poise of the E1 right-left-harpoons  E2 balance. Nevertheless, they do reflect, at least partly, a change in the rates of limiting steps of its reaction cycle.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Cell Culture and Membrane Preparation-- HeLa cells expressing the rat alpha 1, alpha 2*, and alpha 3* enzymes (a generous gift from Dr. J. B Lingrel) were grown in Dulbecco's modified Eagle's medium supplemented with 10% newborn calf serum, 100 units of penicillin G, 100 µg/ml streptomycin, and 1 µM ouabain as described previously (9).

NaI-treated microsomal membranes were prepared from the transfected HeLa cells as described elsewhere (8, 12). Protein concentrations of the membrane preparations were determined using the Lowry assay as modified by Markwell et al. (13).

Enzyme Assays-- Na,K-ATPase activity was measured as the release of 32Pi from [gamma -32P]ATP as previously described (14). Unless indicated otherwise, the membranes were preincubated for 10 min at 37 °C with all reactants added except ATP. The reaction was initiated by the addition of [gamma -32P]ATP. Final concentrations for Na,K-ATPase activity measurements were 100 mM NaCl, 10 mM KCl, 3 mM MgSO4, 20 mM histidine (pH 7.4), 5 mM EGTA (pH 7.4), and 5 µM ouabain (Sigma). To analyze kinetic behavior under various conditions and unless indicated otherwise, Na,K-ATPase measurements were carried out using 1 mM ATP as in our earlier studies (cf. Refs. 9-11), which is reasonably close (>= 75%) to saturation. This was done in order to maximize the precision (maximal percentage of Pi release due to Na,K-ATPase) of the kinetic studies of the relatively low activity transfected cells. A final concentration of 5 mM ouabain was used to determine base-line hydrolysis activity. Na-ATPase activity was measured at 1 µM ATP as described previously (9), with varying amounts of added KCl and choline chloride to maintain constant chloride (40 mM) concentration. Where indicated, Vmax values shown were derived from activities measured at 1 mM ATP using values of K'ATP given in Table I.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Apparent kinetic constants for substrate affinities of rat alpha 1, alpha 2*, and alpha 3*
Values for apparent kinetic constants were determined using a noncooperative model of ligand binding as in papers cited below. Values shown are the mean ± S.D. of the number of experiments shown in parenthesis.

For studies of vanadate sensitivity, inorganic orthovanadate (Fisher) solutions were prepared fresh prior to the experiment and added with the [gamma -32P]ATP solution to initiate the reaction at the indicated concentrations. Values of Na,K-ATPase obtained at various vanadate concentrations, expressed as percentages of that obtained in the absence of vanadate, were analyzed by fitting the data to a one-compartment model using a nonlinear least square analysis of a general logistic function as described elsewhere (15, 16).

Effects of varying pH on Na-ATPase or Na,K-ATPase were determined as indicated in the above enzyme assays except using 30 mM MES1/Tris (pH values of 6.2 and 6.5) or 30 mM Tris/HCl (pH >= 7.0) instead of histidine.

Phosphoenzyme Determination-- Phosphoenzyme levels were determined as described earlier (11). Briefly, membranes were preincubated with ouabain (20 µM ouabain, 0.4 mM MgSO4, and 10 mM glycylglycine-Tris (pH 7.4)) for 10 min at 37 °C to inhibit endogenous HeLa Na,K-ATPase. The suspension was then treated with oligomycin (0.2 mg/ml) for 1 min at room temperature. Phosphorylation was then carried out in a total volume of 200 µl at 0 °C for 10 s with 100 mM NaCl, 10 mM glycylglycine-Tris (pH 7.4), 5 mM EGTA (pH 7.4), 1 mM MgSO4, and 1 µM [gamma -32P]ATP (specific activity, 10,000-20,000 cpm/pmol). Base-line activity was determined by replacing 100 mM NaCl with 50 mM KCl and 50 mM choline chloride and phosphorylating the enzyme in the absence of oligomycin.

Formation of K+-occluded Enzyme-- Assays for K+ dependence of K+-occlusion (E1 + K+ left-right-arrow E2(K)), where E1 is the K+-free enzyme and E2(K) is the occluded enzyme, and the rate of deocclusion (E2(K) right-arrow E1 + K+) were measured indirectly as described elsewhere (11) with the modifications described by Therien and Blostein (17).

At least two different membrane preparations were assayed, and the data presented are representative of at least three independent experiments. Each value shown is the mean ± S.D. of triplicate determinations.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In the experiments described below, the properties of alpha 2* and alpha 3* are described in terms of their similarities or differences relative to the ubiquitous alpha 1 isoform.

Assessment of Differences in the E1/E2 Conformational Equilibrium

Vanadate Sensitivity-- Inorganic orthovanadate is a transition state analog of inorganic phosphate that binds to P-type ATPases in the form of the enzyme from which phosphate is released in the E2 conformation (18). Accordingly, sensitivity of these enzymes to vanadate inhibition is a measure of the proportion of enzyme in the E2 conformation during steady-state catalysis. Thus, for mutants of various P-type pumps, including plant and yeast proton pumps and the Na,K-ATPase, this criterion has provided insight into shifts in the E1/E2 distribution (for recent examples, see Refs. 19-21). From the present comparative analysis of the vanadate sensitivity of the highly homologous alpha 1, alpha 2*, and alpha 3* Na,K-ATPase isoforms, it is evident that the Na,K-ATPase activity of alpha 2* is ~20-fold less sensitive to vanadate inhibition than alpha 1 (Fig. 1A), suggesting a shift in the E1/E2 distribution toward E1. In contrast, no significant difference in vanadate sensitivity of alpha 3* compared with alpha 1 could be detected. Although the representative experiment shown in Fig. 1A was carried out at 1 mM ATP and 3 mM MgCl2, similar results (not shown) were obtained at 3 mM ATP, with 5 mM MgCl2 added to maintain a 2 mM excess of Mg2+ (IC50 values were 0.80 ± 0.15, 12.1 ± 4.3, and 1.2 ± 0.4 µM for alpha 1, alpha 2*, and alpha 3*, respectively). Fig. 1B shows that similar results were also obtained when pump turnover was measured in the absence of K+ (Na-ATPase activity), precluding effects of vanadate secondary to differences in interactions with K+.


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 1.   Vanadate sensitivity of Na,K-ATPase and Na-ATPase activity. ATP hydrolysis at varying vanadate concentrations was determined as described under "Experimental Procedures." Representative experiments are shown. A, effect of vanadate on Na,K-ATPase activity. Data are presented as percentage of Na,K-ATPase activity (control) measured in the absence of vanadate. Control activities were as follows: 194.62 ± 3.29, 143.53 ± 2.22, and 49.40 ± 3.14 nmol/(mg × min) for alpha 1, alpha 2*, and alpha 3*, respectively. IC50 values for vanadate inhibition were as follows: alpha 1, 3.25 ± 0.65 µM; alpha 2*, 114 ± 0.2 µM (p < 0.005 relative to alpha 1); and alpha 3*, 3.30 ± 0.61 µM. B, effect of vanadate on Na-ATPase activity. IC50 values for vanadate inhibition were as follows: alpha 1, 0.24 ± 0.01 µM; alpha 2*, 6.93 ± 2.10 µM (p < 0.005 relative to alpha 1); and alpha 3*, 0.11 ± 0.01 µM. open circle , alpha 1; , alpha 2*; diamond , alpha 3*.

Catalytic Turnover-- Catalytic turnover of the Na,K-ATPase is estimated as the ratio of Vmax to EPmax, the latter measured at 0 °C in the presence of 100 mM NaCl, with K+ omitted and oligomycin added to trap the enzyme in the (Na)E1P state (see "Experimental Procedures"). As shown in Table II, in the presence of K+ (Na,K-ATPase mode), the catalytic turnover of alpha 2* is ~40% that of alpha 1 as observed previously (9). The turnover of alpha 3* is also lower (~50% of alpha 1). In contrast, when the turnover of Na-ATPase is estimated as the product of Na-ATPase/Na,K-ATPase and Vmax(Na,K-ATPase)/EPmax, the turnover of alpha 3* is similar (20 mM Na+; Table II) or even higher (100 mM Na+; not shown) than that of alpha 1, the former probably reflecting the lower K'Na for alpha 3*. Turnover of alpha 2* remains reduced in both the presence and absence of K+.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Catalytic turnover in absence and presence of K+
Na,K-ATPase turnover values were obtained from the ratio of Na,K-ATPase activity measured at 37 °C in the presence of 100 mM NaCl, 10 mM KCl, and 1 mM ATP, to a maximal amount of EP measured at 0 °C in the presence of 100 mM NaCl, 1 µM ATP, and 20 µg/ml oligomycin. S.D. values of the ratios were obtained from a Monte Carlo simulation of a joint probability distribution. Na-ATPase/Na,K-ATPase values are the averages of the ratios of Na-ATPase to Na,K-ATPase of three separate membrane preparations, where Na-ATPase was carried out at 20 mM NaCl as described under "Experimental Procedures." Na-ATPase turnover (a × b) was estimated as the product of the Na,K-ATPase turnover (a) and the Na-ATPase/Na,K-ATPase ratio (b). Shown are the mean values ± S.D.

pH Sensitivity-- The pH sensitivity profile of Na,K-ATPase and its relevance to the issue of rate-limiting reaction(s) were addressed in earlier studies of Forbush and Klodos (22). Their experiments showed that the pathway involving deocclusion of K+ (E2(K) right-arrow E1) is partially rate-limiting at acidic pH, whereas the E1 right-arrow E1P and E1P right-arrow E2P processes are more rate-limiting at alkaline and neutral pH, respectively. In the present study, we compared the pH profiles of the three isoforms over the pH range of 6.0-8.5. As shown in Fig. 2, the activity of all three isoforms declines as pH is decreased below or increased above the optimal. Compared with alpha 1, the activity of alpha 2* is diminished to a lesser extent at acidic pH and more at alkaline pH, consistent with relatively faster E2(K) right-arrow E1 and slower E1 right-arrowright-arrow E2P transitions and hence with a preponderance of enzyme in E1 state(s). Although the pH profile of alpha 3* resembles that of alpha 1 at acidic pH, it decreases more significantly than alpha 1 on the alkaline side of the optimum, the significance of which is discussed below.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 2.   pH dependence of Na,K-ATPase activity. Na,K-ATPase activity was measured in the presence of 100 mM NaCl, 10 mM KCl, 3 mM MgSO4, 1 mM EGTA with either 30 mM MES (pH 6.5) or 30 mM Tris/HCl (pH >= 7.0) as described under "Experimental Procedures." The Na,K-ATPase activities corresponding to 100% were 260.70 ± 0.93, 170.29 ± 2.68, and 192.21 ± 1.87 nmol/(mg × min) for alpha 1, alpha 2*, and alpha 3*, respectively. pH values indicated were measured at room temperature. Symbols are as described in legend to Fig. 1.

Distinct Interactions with Ligands: Comparison of alpha 3* with alpha 1 and alpha 2*

Since the differences in ligand binding affinities of alpha 3* and alpha 1 hold true despite their similar sensitivities to vanadate, it may be inferred that alpha 3* differs from alpha 1 primarily in its interaction with alkali cation ligands. Nevertheless, certain aspects of alpha 3* kinetic behavior have remained enigmatic and a further comparative analysis of ligand interactions was carried out to explore the mechanistic basis for alpha 3*-specific properties.

Cytoplasmic Na+ Effects and the Role of Li+ as a Na+ Congener-- To determine whether alpha 3* has an intrinsically lower affinity for Na+, ATP hydrolysis was measured in the absence of K+ and with the Na+ concentration varied up to 10 mM to favor interactions primarily with cytoplasmic Na+ activation sites. Comparisons of alpha 3* and alpha 1 were carried out at pH values of 6.2, 7.4, and 8.0. The results shown in Fig. 3 indicate that large differences in K'Na persist at all pH values tested, consistent with an intrinsic difference in apparent Na+ affinity between alpha 1 and alpha 3*. For alpha 3* compared with alpha 1, respectively, K'Na values were 0.125 ± 0.036 and 0.552 ± 0.018 mM at pH 6.2, 0.046 ± 0.005 and 0.335 ± 0.046 mM at pH 7.4, and 0.066 ± 0.030 and 0.753 ± 0.372 mM at pH 8.0 (p < 0.05 at all pH values).


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 3.   Na+ activation kinetics of alpha 1 and alpha 3* at varying pH. Na-ATPase activity was measured in the presence of 1 µM ATP with varying concentrations of NaCl as indicated. Data are presented as percentage of maximal Na-ATPase activity (control) measured at 10 mM NaCl. pH values shown were measured at room temperature. The data were fit to a noncooperative three-site model as described by Garay and Garrahan (23); i.e. v = Vmax/(1 + K'Na/[Na+])3, where K'Na is the apparent affinity for intracellular Na+. K'Na values were 0.125 ± 0.036 and 0.552 ± 0.018 mM at pH 6.2, 0.046 ± 0.005 and 0.335 ± 0.046 mM at pH 7.4, and 0.066 ± 0.030 and 0.753 ± 0.372 mM at pH 8.0 for alpha 3* compared with alpha 1 (p < 0.05 at all pH values). Symbols are as described in the legend to Fig. 1.

In the case of alpha 1, Li+ can act as a congener of cytoplasmic Na+ as well as extracellular K+ (24, 25). The experiment shown in Fig. 4 was carried out to test whether this holds true for alpha 2* and alpha 3*. The results show that Li+ can replace Na+ and stimulate ATP hydrolysis for both the alpha 1 and alpha 2* enzymes but not in the case of alpha 3*. This finding underscores the large difference in cation selectivity of alpha 3* compared with alpha 1 or alpha 2*.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 4.   Li+-stimulated ATP hydrolysis. ATP hydrolysis at varying LiCl concentrations was determined at 1 µM ATP as described under "Experimental Procedures." The data are expressed as percentage of maximal Li+-ATPase activity. Symbols are as described in the legend to Fig. 1.

Interactions with Extracellular K+ and Li+-- In an earlier study, we showed that K+ stimulates Na-ATPase activity of alpha 2* at micromolar ATP concentration but inhibits both alpha 1 and alpha 3*. The explanation that E2(K) right-arrow E1 of alpha 2* is faster relative to other reactions of the cycle was substantiated by measurements of the E2(K) right-arrow E1 rate of alpha 1 and alpha 2* (9). With Li+ replacing K+, Na-ATPase activity of all three isoforms was stimulated in the order alpha 2* approx  alpha 3* alpha 1, consistent with Li+ acting as a congener of K+ and with a known faster deocclusion compared with K+ (26). Nevertheless, the observation that K+ inhibits alpha 1 and alpha 3* to similar extents whereas Li+ stimulates alpha 2* and alpha 3* but not alpha 1 suggests distinct properties of alpha 3* with respect to interaction with extracellular alkali cations and/or the rate of another reaction step. Therefore, to gain insight into the basis for these isoform-distinct effects of Li+ and K+, we compared alpha 3* and alpha 1 with respect to rates of K+ occlusion and deocclusion as described below.

K0.5 for K+ Occlusion-- The K+ dependence for formation of the K+-occluded enzyme, E1 + K+ left-right-arrow E2(K), was measured indirectly as the decrease in phosphoenzyme (E32P formed by phosphorylation with [gamma -32P]ATP) following equilibration of the enzyme in the absence or presence of varying concentrations of K+ as described previously (9, 27)). The decrease in E32P resulting from preincubation with K+ is a measure of the amount of E2(K+). Fig. 5 shows a representative K+-occlusion profile of alpha 3* and alpha 1. Using the simple model Bmax[S]/(K0.5 + [S]) to describe K+ occlusion, where Bmax is the maximally bound enzyme (28), the values of the equilibrium constant for K+ occlusion, K0.5, were 0.031 ± 0.007 and 0.046 ± 0.008 mM for alpha 1 and alpha 3*, respectively, and, therefore, not significantly different (p > 0.5). (This contrasts with the >= 3-fold increase in K0.5 for alpha 2* compared with alpha 1 (11).) Maximum formation of E2(K) with both alpha 1 and alpha 3* was observed at 1 mM KCl as shown previously for alpha 1 (11).


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 5.   Occlusion of K+ at 0 °C. Formation of EP at various concentrations of KCl was determined as described under "Experimental Procedures." Data are presented as percentage of maximal E32P, which is the difference of E32P formed in the absence of K+ minus E32P formed in the presence of K+. Values of maximal E32P were (pmol/mg) 18.66 ± 0.76, and 14.47 ± 0.34, for alpha 1 and alpha 3*, respectively. The results were fitted to a simple model of K+ binding (Bmax [K+]/(K0.5 + [K+])). Symbols are as described in the legend to Fig. 1.

E2(K) right-arrow E1-- The rate of the E2(K) right-arrow E1 deocclusion process was estimated indirectly by measuring the rate of E1 formation from E2(K) as described previously (11, 27). The results of the representative experiment shown in Fig. 6 indicate that the K+ deocclusion rate for alpha 3*, similar to that determined earlier for alpha 2* (11), is faster than that of alpha 1. The fold increase obtained in three similar independent experiments was 3.4 ± 0.5. Since K0.5 for K+ occlusion is similar for alpha 1 and alpha 3*, the rate of E1 + K+ right-arrowright-arrow E2(K) must also be 3-fold faster for alpha 3*. The implication of the faster deocclusion vis-à-vis the effects of K+ on Na-ATPase at micromolar ATP concentration is considered below.


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 6.   Rate of formation of E1 from E2(K) at 10 °C. Formation of E1 was determined at the indicated times following occlusion of K+ as described under "Experimental Procedures." Data are presented as percentage of control E32P, which is the difference ((E32P formed in the absence of K+ at 0 °C) minus (E32P formed in the presence of 4 mM K+ at 10 °C))/((E32P formed in the absence of K+ at 0 °C) minus (E32P formed in the presence of 4 mM K+ at 0 °C). Symbols are as described in legend to Fig. 1.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In the present study, we have extended earlier comparisons of the rat alpha 1, alpha 2*, and alpha 3* isoforms expressed in the same (HeLa) cell environment (8, 10) to gain insight into the mechanistic basis for their distinct behavior. The following discussion focuses on the properties of alpha 2* and alpha 3* as they relate to those of the ubiquitous alpha 1 isoform.

The alpha 2 Isoform-- From a comparison with the ubiquitous alpha 1 isoform, it is now clear that the main distinguishing property of the alpha 2* isoform is its poise in conformational equilibrium in favor of E1 forms. There are several observations in support of this conclusion. Thus, earlier studies showed that the E2(K) right-arrow E1 transition associated with K+-deocclusion is faster for alpha 2* than for alpha 1 and that the apparent affinity for low affinity ATP binding is 2-3 times higher for alpha 2* compared with alpha 1 (8-10). Further supportive evidence is the present finding of a ~20-fold increase in IC50 for vanadate inhibition of alpha 2* compared with either alpha 1 or alpha 3*, indicating a shift in equilibrium away from the E2 state(s). Another point of evidence is the alpha 2*-distinct pH profile. As already discussed, the smaller decrease in activity of alpha 2* at acidic pH and greater decrease at alkaline pH also implicate shifts of rates of partial reactions in favor of E1 form(s).

It is noteworthy that the distinctive behavior of alpha 2* vis-à-vis alpha 1 is remarkably similar to the behavior of alpha 1 mutants obtained by deletion of the first 32 residues from the amino terminus and by a Glu233 right-arrow Lys substitution in the cytoplasmic loop between M2 and M3. Generally similar differences from alpha 1 were obtained in the aforementioned properties for these mutants, including faster E2(K) right-arrow E1, slower catalytic turnover, lower K'ATP for low affinity ATP binding, and decreased sensitivity of Na,K-ATPase activity to vanadate inhibition, all leading to the conclusion that these are mutants with the E1 right-left-harpoons  E2 equilibrium shifted toward E1 (21, 29). Current studies aimed to identify distinct cytoplasmic regions of alpha 2* that underlie its altered conformational transitions are under way.

The alpha 3 Isoform-- A mechanistic explanation for the distinct kinetic properties of alpha 3* is more complex. As shown previously, differences in K+/Na+ antagonism at cytoplasmic Na+ activation sites underlie much of the variability in K'Na noted in studies with intact cells comprising high intracellular K+ versus studies with membrane fragments analyzed at relatively low K+ concentration (see Ref. 30 and Table I). When the complexity of competing effects of Na+ and K+ is eliminated by analyzing the reaction cycle in the absence of K+, and under conditions of enzyme turnover with Na+ varied up to 10 mM to limit its interaction to primarily cytoplasm-facing sites, a markedly lower apparent affinity of alpha 3* for Na+ is observed (Fig. 3). This behavior supports the notion of alpha 3-distinct cation ligation. It is noteworthy that an earlier analysis of a series of alpha 1/alpha 3* chimeras expressed in HeLa cells failed to identify a region clearly responsible for the differences in apparent Na+ affinity between the two isoforms (31). This is not surprising in view of the present experiments, which indicate that a difference in cation binding or selectivity is not the sole determinant of alpha 3- versus alpha 1-distinct apparent affinities for Na+ and K+ activation as discussed further below. The remarkable ability of alpha 3* to utilize Na+ over Li+ focuses on its distinctive cation interactions with cytoplasmic Na+ and should be an invaluable criterion for identification of specific residues comprising either the selectivity filter, gate, or Na+ binding pocket of the catalytic subunit.

Despite the evidence of an intrinsic difference in K'Na of alpha 3* compared with alpha 1 and alpha 2*, several observations suggest that the apparent Na+ and K+ affinities are affected, in an isoform-specific manner, by the rates of reactions associated with Na+ and K+ translocation. Thus, if one considers the sequence E1 + Na+ + ATP left-right-arrow Na·E1P left-right-arrow E2P + Na+, a decrease in the rate of E1P formation from E1 or a higher rate of the subsequent E1P right-arrow E2P reaction should effectively increase K'Na. The greater decline in activity of alpha 3* at alkaline pH suggests greater rate limitation of the former reaction in the case of alpha 3* (cf. Ref. 22). Furthermore, the conclusion that the phosphorylation reaction also contributes to rate limitation under Vmax conditions at physiological pH is supported by the lower turnover of alpha 3* compared with alpha 1 under near Vmax conditions in the presence of both Na+ and K+ (Na,K-ATPase activity).

On the other hand, compared with alpha 1, the Na·E1P right-arrow E2P transition is probably intrinsically faster for alpha 3* for the following reason. Inhibition of Na-ATPase by low concentrations of K+ is observed at micromolar ATP concentration with both the alpha 1 and alpha 3*, but not the alpha 2*, isoform (9). For alpha 1, this behavior is thought to be a consequence of the rate-limiting E2(K) right-arrow E1 process, which at low ATP is slower than E2 right-arrow E1 in the absence of K+. This holds true despite the evidence for an intrinsically faster rate of formation of E1 from E2(K) noted in this study.

The most straightforward explanation for the foregoing paradox is that reaction steps comprising the conformational transition of phosphoenzyme that lead to release of three Na+ ions to the extracellular milieu (Na3E1P left-right-arrow E2P + 3Na+) as well as the K+ deocclusion process (E2(K) right-arrow E1 + K+) are proportionately faster for alpha 3*, with the result that the K+ deocclusion process is similarly rate-limiting at low ATP concentration, for alpha 3* as for alpha 1. Relevant to the presumably faster Na3E1P right-left-harpoons  E2P + 3Na+ for alpha 3* is the observation that the human alpha 3 enzyme, expressed in Xenopus oocytes, shows almost no voltage dependence of pump current over the range of -150 to +50 mV in the presence of extracellular Na+ and K+ (32). (The greater voltage dependence of alpha 2 observed in that study is consistent with more rate limitation of this step as well as with the preference of this isoform for the E1 conformation.) This led these authors to suggest that there is an isoform-specific difference in the backward rate constant for the Na+ release step. Accordingly, less rate limitation of the Na3·E1P left-right-arrow E2P + 3Na+ process would be consistent with the loss of voltage dependence of the alpha 3-catalyzed reaction in the presence of extracellular Na+. Decreased voltage dependence may, in turn, reflect either the decreased affinity of alpha 3 for allosteric Na+ inhibition of pump flux (33) or a decrease in Na+ antagonism of K+ext binding (see Ref. 34). Thus, in either case, an increase in the relative rate of the forward E1P left-right-arrow E2P process of the Na+ and K+ reaction cycle is observed. Studies are currently under way to compare the voltage dependence of pump current in rat isoform-transfected HeLa cells.

With the human enzyme, little, if any difference in K'K of alpha 3 was observed except under conditions of extreme hyperpolarization in presence of Na+ext (32); in Sf-9 cells, the apparent affinity for K+ was somewhat lower for alpha 3 compared with alpha 1 (6). It is unlikely that the difference in K'K seen with the rat alpha 3* enzyme is due to the mutation to ouabain resistance, since the difference persists when ouabain-resistant rat kidney alpha 1 and rat axolemma (~70% alpha 3) enzymes are compared (30). More likely, the discordant findings suggest that the isoforms do not differ in their intrinsic K+ binding/occlusion but rather in the relative rates of reaction(s) associated with K+-activated dephosphorylation of E2P. Accordingly, an increase in the rate of the proceeding K+ deocclusion process [E2(K) right-arrow E1] or preceding E1P right-arrow E2P transition would effectively decrease and increase, respectively, the apparent affinity for K+. Although the present study indicates that these two processes are faster for alpha 3, the relative magnitudes of the increases probably differ when the enzyme is analyzed in both a different membrane environment and at a different temperature (Xenopus membranes assayed at ambient temperature (32) versus HeLa membranes assayed at 37 °C).

In conclusion, the main distinguishing feature of alpha 2* is its shift in conformational equilibrium toward E1. On the other hand, the alpha 3* isoform resembles alpha 1 in its conformational equilibrium. Its lower apparent affinity for Na+cyt is due, in large part, to intrinsic differences in cation binding and, to some extent, to differences in rates of limiting forward and reverse steps in the catalytic cycle. The higher apparent affinity of alpha 3 for K+ext is probably secondary to differences in the rates of reactions preceding and subsequent to K+-activated dephosphorylation.

Although the relationship between the kinetics of the individual isoforms and their distinct physiological roles in various tissues remains elusive, a few clues are notable. In neuronal tissue, the lower affinity of alpha 3 for Na+cyt suggests that alpha 3 may only be activated when the Na+cyt concentration reaches its maximum following repeated firing, possibly acting as a "spare pump" to restore membrane potential (8, 10). It is also plausible that the higher ATP affinity of alpha 3 compared with the ubiquitous alpha 1 allows it to function at the low ATP concentrations found near the membrane (7). This alpha 3-distinct property (alpha 2 as well) is reminiscent of the shift in ATP affinity of alpha 1 conferred by interaction with the gamma  subunit in the renal outer medulla, which may allow the pump to function more efficiently under the near anoxic conditions found in this portion of the kidney (35). It is also plausible that the higher apparent ATP affinity of alpha 2 and the maintenance of activity under acidic and metabolically depleted conditions are advantageous for skeletal muscle tissue during exercise. In fact, it has been shown that in both the rat (36) and human (37) exercise induces the translocation of alpha 2beta 1 pumps from an intracellular pool to the plasma membrane of skeletal muscle. That the presence of alpha 3 in neonatal rat cardiac myocytes, with its low Na+ affinity, would be particularly effective in raising cytosolic Ca2+ is supported by the coincidence of the switch from alpha 3 to alpha 2 to the shortening of the action potential duration in rat heart during ontogeny (38-40). Although studies with cardiac myocytes in which alpha 1 is down-regulated implicate alpha 1 as having a major role in regulation of cardiac Ca2+ (41), a specific role of alpha 2 in Ca2+ signaling during heart contraction was clearly evidenced in studies of genetically reduced levels of alpha 2 in the heart (42). The information provided by the present study taken together with earlier studies of isoform-specific kinetics represents an important step toward a better understanding of the basis for their distinct roles in native tissues.

    ACKNOWLEDGEMENTS

We thank Drs. E. Jewell and J. B Lingrel for the rat isoform-transfected cells and Dr. R. Daniel Peluffo for helpful comments on the manuscript. The excellent technical assistance of Rosemarie Scanzano is gratefully acknowledged.

    FOOTNOTES

* This work was supported by grants from the Medical Research Council of Canada and Quebec Heart and Stroke Foundation (to R. B.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Supported by a predoctoral traineeship from the Heart and Stroke Foundation of Canada.

Published, JBC Papers in Press, June 26, 2001, DOI 10.1074/jbc.M103720200

§ To whom correspondence should be addressed: Montreal General Hospital, 1650 Cedar Ave., Montreal, Quebec H3G 1A4, Canada. Tel.: 514-937-6011 (ext. 4501); Fax: 514-934-8332.

    ABBREVIATIONS

The abbreviations used are: MES, 4-morpholineethanesulfonic acid; EP, the phosphoenzyme form of the Na,K-ATPase; Na+cyt, intracellular Na+; K+ext, extracellular K+.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Sweadner, K. J. (1989) Biochim. Biophys. Acta 988, 185-220
2. Lingrel, J. B, and Kuntzweiler, T. (1994) J. Biol. Chem. 269, 19659-19662
3. Mercer, R. W., Biemesderfer, D., Bliss, D. P., Jr., Collins, J. H., and Forbush, B., III (1993) J. Cell Biol. 121, 579-586
4. Therien, A. G., and Blostein, R. (2000) Am. J. Physiol. 279, C541-C566
5. Woo, A. L., James, P. F., and Lingrel, J. B (1999) J. Membr. Biol. 169, 39-44
6. Woo, A. L., James, P. F., and Lingrel, J. B (2000) J. Biol. Chem. 275, 20693-20699
7. Blanco, G., and Mercer, R. W. (1998) Am. J. Physiol. 275, F633-F650
8. Jewell, E. A., and Lingrel, J. B (1991) J. Biol. Chem. 266, 16925-16930
9. Daly, S. E., Lane, L. K., and Blostein, R. (1994) J. Biol. Chem. 269, 23944-23948
10. Munzer, J. S., Daly, S. E., Jewell-Motz, E. A., Lingrel, J. B, and Blostein, R. (1994) J. Biol. Chem. 269, 16668-16676
11. Daly, S. E., Lane, L. K., and Blostein, R. (1996) J. Biol. Chem. 271, 23683-23689
12. Lane, L. K., Feldmann, J. M., Flarsheim, C. E., and Rybczynski, C. L. (1993) J. Biol. Chem. 268, 17930-17934
13. Markwell, M. A., Haas, S. M., Tolbert, N. E., and Bieber, L. L. (1981) Methods Enzymol. 72, 296-303
14. Blostein, R. (1988) Methods Enzymol. 156, 171-178
15. DeLean, A., Munson, P. J., and Rodbard, D. (1978) Am. J. Physiol. 235, E97-E102
16. Berrebi-Bertrand, I., Maixent, J. M., Christe, G., and Lelievre, L. G. (1990) Biochim. Biophys. Acta 1021, 148-156
17. Therien, A. G., and Blostein, R. (1999) Am. J. Physiol. 277, C891-C898
18. Cantley, L. C., Jr., Cantley, L. G., and Josephson, L. (1978) J. Biol. Chem. 253, 7361-7368
19. Ambesi, A., Miranda, M., Allen, K. E., and Slayman, C. W. (2000) J. Biol. Chem. 275, 20545-20550
20. Buch-Pedersen, M. J., Venema, K., Serrano, R., and Palmgren, M. G. (2000) J. Biol. Chem. 275, 39167-39173
21. Boxenbaum, N., Daly, S. E., Javaid, Z. Z., Lane, L. K., and Blostein, R. (1998) J. Biol. Chem. 273, 23086-23092
22. Forbush, B., III, and Klodos, I. (1991) Soc. Gen. Physiol. Ser. 46, 210-225
23. Garay, R. P., and Garrahan, P. J. (1973) J. Physiol. (Lond.) 231, 297-325
24. Blostein, R., Pershadsingh, H. A., Drapeau, P., and Chu, L. (1979) in Na, K-ATPase: Structure and Kinetics (Skou, J. C. , and Norby, J. G., eds) , p. 233, Academic Press, Inc., New York
25. Dunham, P. B., and Senyk, O. (1977) Proc. Natl. Acad. Sci. U. S. A. 74, 3099-3103
26. Post, R. L., Hegyvary, C., and Kume, S. (1972) J. Biol. Chem. 247, 6530-6540
27. Therien, A. G., and Blostein, R. (1999) Am. J. Physiol. 277, C891-C898
28. Shani, M., Goldschleger, R., and Karlish, S. J. (1987) Biochim. Biophys. Acta 904, 13-21
29. Daly, S. E., Blostein, R., and Lane, L. K. (1997) J. Biol. Chem. 272, 6341-6347
30. Therien, A. G., Nestor, N. B., Ball, W. J., and Blostein, R. (1996) J. Biol. Chem. 271, 7104-7112
31. Jewell, E. A., and Lingrel, J. B (1992) Ann. N. Y. Acad. Sci. 671, 120-132
32. Crambert, G., Hasler, U., Beggah, A. T., Yu, C., Modyanov, N. N., Horisberger, J. D., Lelievre, L., and Geering, K. (2000) J. Biol. Chem. 275, 1976-1986
33. Balshaw, D. M., Millette, L. A., Tepperman, K., and Wallick, E. T. (2000) Biophys. J. 79, 853-862
34. Sachs, J. R. (1977) J. Physiol. 264, 449-470
35. Therien, A. G., Karlish, S. J., and Blostein, R. (1999) J. Biol. Chem. 274, 12252-12256
36. Tsakiridis, T., Wong, P. P., Liu, Z., Rodgers, C. D., Vranic, M., and Klip, A. (1996) J. Appl. Physiol. 80, 699-705
37. Juel, C., Nielsen, J. J., and Bangsbo, J. (2000) Am. J. Physiol. 278, R1107-R1110
38. Lingrel, J. B, Orlowski, J., Shull, M. M., and Price, E. M. (1990) Prog. Nucleic Acids Res. Mol. Biol. 38, 37-89
39. Lucchesi, P. A., and Sweadner, K. J. (1991) J. Biol. Chem. 266, 9327-9331
40. Berrebi-Bertrand, I., and Maixent, J. M. (1994) FEBS Lett. 348, 55-60
41. Komehani, P., Askari, A., Liu, J., Xie, Z., and Askari, F. K. (2001) Am. J. Physiol. 280, H1415-H1421
42. James, P. F., Grupp, I. L., Grupp, G., Woo, A. L., Askew, G. R., Croyle, M. L., Walsh, R. A., and Lingrel, J. B (1999) Mol. Cell 3, 555-63


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Edwards and T. L. Pallone
Ouabain modulation of cellular calcium stores and signaling
Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1518 - F1532.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Edwards and T. L. Pallone
Modification of cytosolic calcium signaling by subplasmalemmal microdomains
Am J Physiol Renal Physiol, June 1, 2007; 292(6): F1827 - F1845.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. E. Moseley, M. T. Williams, T. L. Schaefer, C. S. Bohanan, J. C. Neumann, M. M. Behbehani, C. V. Vorhees, and J. B Lingrel
Deficiency in Na,K-ATPase {alpha} Isoform Genes Alters Spatial Learning, Motor Activity, and Anxiety in Mice
J. Neurosci., January 17, 2007; 27(3): 616 - 626.
[Abstract] [Full Text] [PDF]


Home page